Accolade Stock News

Charles Schwab Investment Management Inc. boosted its position in shares of Accolade, Inc. (NASDAQ:ACCD) by 32.2% during the 2nd quarter, HoldingsChannel reports. The fund owned 184,755 shares of the companys stock after buying an additional 45,038 shares during the quarter. Charles Schwab Investment Management Inc.s holdings in Accolade were worth $10,035,000 as of its most []

Shares of Accolade, Inc. (NASDAQ:ACCD) have received an average recommendation of Buy from the twelve brokerages that are covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation and eleven have assigned a buy recommendation to the company. The average 12-month price target among brokers that have issued a []

Accolade, Inc. (NASDAQ:ACCD)s share price hit a new 52-week low during trading on Monday . The stock traded as low as $34.81 and last traded at $34.85, with a volume of 51624 shares changing hands. The stock had previously closed at $36.38. A number of equities research analysts recently commented on ACCD shares. Berenberg Bank []

Related Stocks: GPRE , TTSH , FISV , GLPG , ASO , TCS , ZETA , ACCD , UIS , OEC , COMP , ALIT , HOME , CSOD , TW , ZM , SPLK , GLDD ,

Accolade has seen continued growth this year.

SEATTLE, Oct. 12, 2021 /PRNewswire/ -- Accolade (Nasdaq: ACCD), a healthcare provider serving millions of people and their families, announced today that WellRight, the provider of the nation's most h

Accolade, Inc. (ACCD) CEO Rajeev Singh on Q2 2022 Results - Earnings Call Transcript

Accolade (ACCD) delivered earnings and revenue surprises of 4.44% and 4.04%, respectively, for the quarter ended August 2021. Do the numbers hold clues to what lies ahead for the stock?

SEATTLE, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal second quarter ended August 31, 2021.

Accolade (ACCD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Health benefits platform company Accolade is expanding its offerings to add two personalized services with an emphasis on mental health, the company announced Tuesday.

SEATTLE, Sept. 21, 2021 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD), the company that provides millions of people and their families with exceptional healthcare, today introduced Personalized Healt

SEATTLE, Sept. 20, 2021 /PRNewswire/ -- WHAT:             Accolade, Inc. (Nasdaq: ACCD) the company that provides millions of people and their families with exceptional healthcare will be m

Accolade Inc (NASDAQ:ACCD) is up 0.7% at $45.31 this morning, after Baird upgraded the healthcare technology name to "outperform" from "neutral.

SEATTLE, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the following upcoming